2013
DOI: 10.1136/bcr-2013-009700
|View full text |Cite
|
Sign up to set email alerts
|

Guillain-Barré syndrome as a paraneoplastic manifestation of disseminated squamous cell carcinoma

Abstract: We describe a 65-year-old woman who developed ascending, symmetrical paraesthesia and weakness. This was on a background of metastatic disseminated squamous cell carcinoma, with a likely recurrent mandibular primary. Serum testing for antiganglioside antibodies was strongly positive. Despite a 5-day course of intravenous immunoglobulin, the patient passed away on day 34 of admission. This is the first case, to our knowledge, of Guillain-Barré syndrome in association with squamous cell carcimoma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…Of the reported cases, seven involve small cell lung cancer [ 3 , 5 - 9 , 11 ] and two involve adenocarcinoma of the lung [ 4 , 10 ]. There is only one other documented case involving squamous cell, however the primary tumor originated from the mandible [ 20 ]. The patient in the reported case of GBS occurring concomitantly with squamous cell was diagnosed with cancer after the onset of ascending paralysis and similarly, did not respond to treatment with intravenous immunoglobulin.…”
Section: Discussionmentioning
confidence: 99%
“…Of the reported cases, seven involve small cell lung cancer [ 3 , 5 - 9 , 11 ] and two involve adenocarcinoma of the lung [ 4 , 10 ]. There is only one other documented case involving squamous cell, however the primary tumor originated from the mandible [ 20 ]. The patient in the reported case of GBS occurring concomitantly with squamous cell was diagnosed with cancer after the onset of ascending paralysis and similarly, did not respond to treatment with intravenous immunoglobulin.…”
Section: Discussionmentioning
confidence: 99%